History
Innomentarium is a health technology company that was originally founded by Jouni Ihme in March 2008. In the inital phase, it functioned as a holding company during his former company’s Innokas Medical ownership restructuring at that time.
“Innokas Medical is the company I established in 1994 and run 20 years having 23M€ revenue and 200 healthtech professionals when I left the company. In 2008 we had a challenging situaton to rearrange the ownership of the company. Actually Innomentarium was established in the forest, in the middle of nowhere in Sarajärvi where I was born. While doing forest work, I was thinking the way to find out the solution in the situation, for the best of the company and its staff’s future. So, originally Innomentarium was born in the tight circumstances to survival. I’m sure it will be seen in the company’s future when we are building our story, as a persistence and innovativeness. In 2010 the holding company’s name was changed to Innokas Yhtymä, officially Innokas Group in English. At the time I wanted to protect the Innomentarium name, so a new company was founded, which became our current Innomentarium,” explains the company’s founder, Jouni Ihme.
“Big changes in my life happened at the end of 2013 when I left Innokas. Long journey from start up to successful and international healthtech company had ended for me. Big changes in your life create also opportunities to do something new. So it made it possible to start to ramp up operations in Innonentarium at the beginning of 2014,” Ihme continues.
The company is built on decades of experience in the international health technology business and medical imaging expertise. “Our passionate goal is to bring additional quality into ordinary people’s lives using novel imaging technologies. In practice that enable better diagnoses and examinations of diseases that have a dramatic impact on people’s health. That can be done in close collaboration with top universities, clinical experts and together with our network of medical imaging professionals,” Ihme continues.
Jouni Ihme, CEO